These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 15960552)

  • 21. [Safety of topical tacrolimus and pimecrolimus in children with atopic dermatitis].
    Rodríguez Orozco AR; Ruiz Reyes H; Marín Hernández D
    Rev Alerg Mex; 2005; 52(4):171-6. PubMed ID: 16268186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids.
    Kirsner RS; Heffernan MP; Antaya R
    Acta Derm Venereol; 2010; 90(1):58-64. PubMed ID: 20107727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New treatments of atopic dermatitis].
    Taïeb A; Boralevi F
    Arch Pediatr; 2005 Apr; 12(4):491-7. PubMed ID: 15808446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema.
    Pitt M; Garside R; Stein K
    Br J Dermatol; 2006 Jun; 154(6):1137-46. PubMed ID: 16704646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mode of topical immunomodulators in the immunological network of atopic dermatitis.
    Novak N; Kwiek B; Bieber T
    Clin Exp Dermatol; 2005 Mar; 30(2):160-4. PubMed ID: 15725246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.
    Chen SL; Yan J; Wang FS
    J Dermatolog Treat; 2010 May; 21(3):144-56. PubMed ID: 20394490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Hultsch T; Kapp A; Spergel J
    Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues.
    Czarnecka-Operacz M; Jenerowicz D
    J Dtsch Dermatol Ges; 2012 Mar; 10(3):167-72. PubMed ID: 21974750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids.
    Poole CD; Chambers C; Allsopp R; Currie CJ
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):674-8. PubMed ID: 20565562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
    Cheer SM; Plosker GL
    Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical use of pimecrolimus in atopic dermatitis: update on the safety and efficacy.
    Werfel T
    J Dtsch Dermatol Ges; 2009 Sep; 7(9):739-42. PubMed ID: 19650820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
    McKenna SP; Whalley D; de Prost Y; Staab D; Huels J; Paul CF; van Assche D
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommendations for pimecrolimus 1% cream in the treatment of mild-to-moderate atopic dermatitis: from medical needs to a new treatment algorithm.
    Luger T; De Raeve L; Gelmetti C; Kakourou T; Katsarou A; Lambert J; Morren MA; Oranje A; Ruer M; Serdaroglu S; Torrelo A; Werfel T
    Eur J Dermatol; 2013; 23(6):758-66. PubMed ID: 24185493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice.
    Lübbe J; Friedlander SF; Cribier B; Morren MA; García-Díez A; Gelmetti C; Hofmann H; Houwing RH; Kownacki S; Langley RG; Virtanen M; Wolff K; Wisseh S; McGeown C; Abrams B; Schneider D;
    Am J Clin Dermatol; 2006; 7(2):121-31. PubMed ID: 16605292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis.
    Emer JJ; Frankel A; Sohn A; Lebwohl M
    J Drugs Dermatol; 2011 Jul; 10(7):735-43. PubMed ID: 21720655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of atopic dermatitis and impact on quality of life: a review with emphasis on topical non-corticosteroids.
    Schiffner R; Schiffner-Rohe J; Landthaler M; Stolz W
    Pharmacoeconomics; 2003; 21(3):159-79. PubMed ID: 12558467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
    Ingram JR; Martin JA; Finlay AY
    Am J Clin Dermatol; 2009; 10(4):229-37. PubMed ID: 19489656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.